This activity is supported by an independent education grant from GSK. This online education program has been designed solely for healthcare professionals in the US. The content is not intended for healthcare professionals in any other country.
Join Angela Branche, MD, for this accredited online teaching session. This module covers the Intake & First Contact and is the first in a series of four modules using real-world clinical scenarios and multidisciplinary perspectives, to explore the latest evidence-based strategies for aligning vaccination conversations across the care continuum.
Participants will gain practical insights into breaking down communication silos, addressing persistent vaccine hesitancy with empathy, and implementing "unified message" protocols essential for increasing equitable vaccine access and protection in clinical practice.
Credits: 0.25 AMA PRA Category 1 Credits™
Launch date: 10 July 2026
Expiration date: 30 June 2027
Estimated time to complete this activity: 25 minutes
Prefer to read instead? Read our Key Clinical Summary here.
Program Highlights
- Identifying the "Four Doors": Navigating missed opportunities for adult vaccination across pharmacy, primary care, inpatient, and community health touchpoints.
- Overcoming Fragmented Messaging: Strategies for aligning the entire care team to provide a consistent, evidence-based "Unified Message" to patients.
- Modern Approaches to Hesitancy: Practical techniques for addressing vaccine concerns and correcting misinformation without damaging the patient-provider relationship.
- Closing the Equity Gap: Utilizing social and structural insights to reach underserved populations and ensure equitable protection for all.
- Coordinating Transitions of Care: Effective protocols for ensuring vaccination status is addressed during hospital intake and discharge.
Who Should Participate
This program is designed for healthcare professionals in the US, involved in preventative care, immunization advocacy, and patient education, including:
- Primary Care Clinicians (Physicians, PAs, and NPs)
- Pharmacists and Pharmacy Technicians
- Infectious Disease Specialists
- Hospitalists and Inpatient Teams
- Public Health Professionals
- Nurses and Care Coordinators
Faculty
Angela Branche, M.D. is an Associate Professor of Medicine at the University of Rochester Medical Center and a leading expert in infectious diseases and vaccinology. As the Co-Principal Investigator for the University of Rochester Vaccine Treatment and Evaluation Unit (UR VTEU), she plays a key role in the clinical development of therapeutics and vaccines for respiratory pathogens, including COVID-19, influenza, and RSV. Dr. Branche earned her medical degree from the American University of the Caribbean and completed her fellowship training at the University of Rochester, where she now combines her clinical practice with research on viral pathogenesis and host immune responses. A member of the NIH Emerging Infections Expert Working Group, she is dedicated to advancing public health through large-scale clinical trials and the study of vaccine biology in adult populations.
Disclosures
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Angela Branche, MD, faculty for this educational activity, has the following relevant financial relationships: Advisory Board for AstraZeneca, GSK, Moderna, Sanofi, Consultant for AstraZeneca, GSK, Moderna, Sanofi, Grant/Research Support from Moderna, Sanofi, Cyanvac, Pfizer, Vaxcyte, Speaker for AstraZeneca, GSK, Moderna, Sanofi.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designate this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 ANCC contact hours.
Pharmacy Continuing Education
Partners designates this continuing education activity for 0.25 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008073-9999-26-219-H06-P)
Type of Activity: Application
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check your NABP account within thirty (30) days to make sure the credit has posted.
Fee Information
There is no fee for this educational activity.